Article info
PDFHeart failure and cardiomyopathies
Original article
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
- Correspondence to Dr Brian Lipworth, Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK; b.j.lipworth{at}dundee.ac.uk
Citation
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
Publication history
- Received February 10, 2016
- Revised May 31, 2016
- Accepted June 7, 2016
- First published July 5, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (11 November 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/